Oh hey, company leadership being transparent about the known successes and shortcoming of their drug that is in development, but still believes based on patient feedback that it can help a lot of people. Sounds terrible!More of the same. Speech perception blah blah. Admitted they have not seen any audiogram improvement and are moving forward realizing this drug doesn't do that. No mention of tinnitus.
Sure but I don't see why you think this means we can't care about potential cures for noise-induced tinnitus. Noise-induced tinnitus is the sort of tinnitus that most people have and which most typically becomes permanent.Tinnitus isn't just from noise damage guys.
Then how come he didn't say that?Also, Franck also acknowledged that FX-322 is likely causing preferential growth of IHC and not OHC based on his response about seeing word scores increase and not audiogram.
Bro, I had perfect hearing until recently, when I damaged my hearing just very slightly on construction site using a jackhammer.More of the same. Speech perception blah blah. Admitted they have not seen any audiogram improvement and are moving forward realizing this drug doesn't do that. No mention of tinnitus.
They said that it mostly restores IHC, not OHC, which are responsible for filtering and clarity. I have listened to most of their podcasts, and since I have damaged my hearing on construction site recently, I can ensure you they are goddamn right about that.Then how come he didn't say that?
See: FX-345.Just curious, I don't know much.
What's stopping Frequency Therapeutics from creating something that can regenerate more hair cells? To me it seems it works but the amount of hair cells it regenerates is underwhelming when the dream drug would do every hair cell. What percent of hair cells grow in a targeted range? Could an approach where they wait a longer period of time for the hair cells to grow and then administer the drug again be effective?
I know there will be a version to go deeper in the cochlea but it seems like even then it might be far from ideal. Have we heard any type of research recently about increased effectiveness? Do you guys think there will be potential ever for a full restore?
I suspect that your experience is a lot more common than is represented by the commenters in this thread, and possibly on Tinnitus Talk in general. It does seem really common on more broad Acquired SNHL sites, where the patients didn't get tinnitus. I did some recent googling on Kevin Franck at Frequencycy Therapeutics, as he has a fairly prominent background, and found that in prior content on hearing loss, he tended to speak more on patients with mild losses first experiencing sound distortion, and things like dysacusis, which are not really measurable at the mild level on standard clinical assessments.Bro, I had perfect hearing until recently, when I damaged my hearing just very slightly on construction site using a jackhammer.
My audiogram is perfect, I have no dB loss, I can hear everything.
Firstly, my problem is that sounds hurt my ears (hyperacusis). Secondly, since I am (or more likely was) a musician. I am not anymore able to really match pitches or filter out sounds as I could before that.
I didn't lose hearing threshold, what I have lost first is clarity, depth of sound understanding, possibility to filter out sounds.
They are god damn right about what they are saying, I am 100% the drug works, because I have read their data + the fact that FX-322 hits only frequencies up to 8000 Hz is reason it won't help ultimately to get back on 100% hearing, but it is far better than nothing.
FX-345 will hit a better part of cochlea, than we can see much greater improvements.
They said that it mostly restores IHC, not OHC, which are responsible for filtering and clarity. I have listened to most of their podcasts, and since I have damaged my hearing on construction site recently, I can ensure you they are goddamn right about that.
First you lose filtering and clarity. I have perfect thresholds, but clarity and filtering is fucked up, and it's depressing.
This. So much this. Except mine is hissing instead of ringing and the reactivity to certain sounds just adds another layer of difficulty to cope. I've kind of gotten used to it and some days the reactivity is much lower, those days are angelic.Even if they can't give me my hearing back, I would love to have the reactivity and ringing go down so that my hearing loss wasn't so obvious every day. If they can achieve that for me I'd gladly pay for it. Time will tell at this point.
There's a pun in there somewhere.there's no gain to be had.
We use extremely old (and I'd say, outdated) ways of evaluating a person's audiological improvement using these drugs. If they can show the cochlea is regenerating, I don't care what the old tests say, that is progress forward. This is a hard problem that many researchers and drug developers have been taking seriously for the better part of 2 decades now and we're making so much progress right now that any new problem researchers run into that they have to move past can really get the pessimists riled up.I suspect that your experience is a lot more common than is represented by the commenters in this thread, and possibly on Tinnitus Talk in general. It does seem really common on more broad Acquired SNHL sites, where the patients didn't get tinnitus. I did some recent googling on Kevin Franck at Frequencycy Therapeutics, as he has a fairly prominent background, and found that in prior content on hearing loss, he tended to speak more on patients with mild losses first experiencing sound distortion, and things like dysacusis, which are not really measurable at the mild level on standard clinical assessments.
Secondly, I've come to notice that there's a fairly vocal minority on this website that are overly skeptical of progress of any hearing loss drug if they don't show improvements in audiometry. Even though the treatments are showing promise in other prominent tests IE: FX-322 with CNC word score, OTO-413 with SIN. Both don't help improve audiograms to my knowledge, but are massive steps to treat an un-met need. The community doesn't yet know if just improving hearing in these areas might be enough to make tinnitus/hyperacusis a little more livable, or may simply reduce progression of the disorder. It's starting to evolve into a cult of negativity. Don't bother feeding into their comments, there's no gain to be had.
IIRC this photo is of a lab guinea pig or something... not a human?We use extremely old (and I'd say, outdated) ways of evaluating a person's audiological improvement using these drugs. If they can show the cochlea is regenerating, I don't care what the old tests say, that is progress forward. This is a hard problem that many researchers and drug developers have been taking seriously for the better part of 2 decades now and we're making so much progress right now that any new problem researchers run into that they have to move past can really get the pessimists riled up.
We need to realize we're going to see multiple solutions to our hearing loss / tinnitus problems in our lifetime whether we're an optimist or pessimist. It's a solvable problem and these people's jobs and careers depend on producing positive results.
View attachment 48644
This is amazing! Screenshot from the video. Imagine how much better you could hear if your ear repaired itself that much!
This video is wild, everyone should watch it. This drug looks really promising, some of these test subjects show shocking improvement. I know we've been researching how the cochlea works for a while but it's wild to see the research come to fruition like it is here.
I mean... Bob Langer?We need a few more geniuses like him but in the absence of which, we'll have to content ourselves with the incremental steps of our research workers and professors.
This is in vivo buddy. I guess once drugs like OTO-413, FX-322 and FX-345 hit the market we will have somewhat of an idea as to whether regenerating hair cells will reverse tinnitus.We use extremely old (and I'd say, outdated) ways of evaluating a person's audiological improvement using these drugs. If they can show the cochlea is regenerating, I don't care what the old tests say, that is progress forward. This is a hard problem that many researchers and drug developers have been taking seriously for the better part of 2 decades now and we're making so much progress right now that any new problem researchers run into that they have to move past can really get the pessimists riled up.
We need to realize we're going to see multiple solutions to our hearing loss / tinnitus problems in our lifetime whether we're an optimist or pessimist. It's a solvable problem and these people's jobs and careers depend on producing positive results.
View attachment 48644
This is amazing! Screenshot from the video. Imagine how much better you could hear if your ear repaired itself that much!
This video is wild, everyone should watch it. This drug looks really promising, some of these test subjects show shocking improvement. I know we've been researching how the cochlea works for a while but it's amazing to see the research come to fruition like it is here.
It was a missed opportunity. The presenter asks the question at 25:45. Franck says 'there's a story there that kind of makes sense' but he doesn't actually explain it.Then how come he didn't say that?
Brian Taylor:It was a missed opportunity. The presenter asks the question at 25:45. Franck says 'there's a story there that kind of makes sense' but he doesn't actually explain it.
Anyway, we'll see how the 208 study unfolds. If it's still the case 65% of patients don't improve and those that do can lose their gains within two years, it's gonna be an uphill battle getting this commercialized.
I think he just glossed over it because they thought it should but it didn't.It was a missed opportunity. The presenter asks the question at 25:45. Franck says 'there's a story there that kind of makes sense' but he doesn't actually explain it.
65% don't improve to a degree that is measurable on current clinical tests; it doesn't mean FX-322 does nothing for them. In the slide I have attached, look at the 71 patients in the treatment group. Notice how the cluster of data points are more concentrated above the baseline rather than having an even distribution both above and below it like the untreated group does. On rough estimation, it looks like approximately 21 treated patients fall below their original baseline while the remaining 50 landed above it. This trend suggests that the majority of patients may experience an ever so slight improvement in WR scores but it isn't measurable as being clinically significant. Sure, the retake variability is + or - 3 words but there is still clearly a trend there.Anyway, we'll see how the 208 study unfolds. If it's still the case 65% of patients don't improve and those that do can lose their gains within two years, it's gonna be an uphill battle getting this commercialized.
Hearing the doorbell or timer go off would fall on pure tone.65% don't improve to a degree that is measurable on current clinical tests; it doesn't mean FX-322 does nothing for them. In the slide I have attached, look at the 71 patients in the treatment group. Notice how the cluster of data points are more concentrated above the baseline rather than having an even distribution both above and below it like the untreated group does. On rough estimation, it looks like approximately 21 treated patients fall below their original baseline while the remaining 50 landed above it. This trend suggests that the majority of patients may experience an ever so slight improvement in WR scores but it isn't measurable as being clinically significant. Sure, the retake variability is + or - 3 words but there is still clearly a trend there.
You may think that is an insignificant improvement for these people but it could make the difference of being able to now faintly hear the oven timer go off or the doorbell ring for some. That is why they have designed their patient questionnaire RADIAL, so they can capture those improvements that aren't being caught by standard clinical tests.
Secondly, vast majority of patients do not lose all of their gains; they lose some of their statistically significant gains but still remain well above baseline; the company has repeatedly said this.
It will not be an uphill battle to get it commercialized; the FDA has already agreed on speech perception as the primary endpoint for the current Phase 2 trial and there are currently zero approved pharmaceutical treatments for hearing loss so I'm sure the FDA will be happy to approve any drug that is shown to be safe and that shows any improvement at all on any clinical hearing exam.
View attachment 48656
Okay, lets correct my analogy then. It would help them distinguish the doorbell from their microwave beep.Hearing the doorbell or timer go off would fall on pure tone.
More like distinguishing from someone saying "hat" or "bat."Okay, lets correct my analogy then. It would help them distinguish the doorbell from their microwave beep.
Hopefully, your reactivity will go away eventually. Since you have fluctuating days where the reactivity is much lower, I see that as a really good sign imo.This. So much this. Except mine is hissing instead of ringing and the reactivity to certain sounds just adds another layer of difficulty to cope. I've kind of gotten used to it and some days the reactivity is much lower, those days are angelic.
This is the most relevant sentence that has been written in this thread in a long time, and also serves as documentable evidence that the @Chad Lawton is in fact a GigaChad.65% don't improve to a degree that is measurable on current clinical tests; it doesn't mean FX-322 does nothing for them.
I think that it should work (and to some extent it has) but they don't know why it isn't working. Barring killing someone and cutting out their ear, there isn't really a way to determine why more ear hair cells aren't being generated or to even see the distribution of hair cells in the human ear after the injection of FX-322.What's stopping Frequency Therapeutics from creating something that can regenerate more hair cells?
One problem is drug delivery. The other is it may not work on the human ear.I think that it should work (and to some extent it has) but they don't know why it isn't working. Barring killing someone and cutting out their ear, there isn't really a way to determine why more ear hair cells aren't being generated or to even see the distribution of hair cells in the human ear after the injection of FX-322.